⚠ Unsupported Browser ⚠ Our site probably won't work so great in Internet Explorer. Please try a more recent version of a major browser like Chrome, Firefox, Safari, or Edge.
enactt1d logo

ENACTT1D

Adults with Type 1 diabetes are at high risk of cardiovascular disease, which can be significantly reduced by a daily cholesterol lowering ‘statin’ tablet. Yet in Australia many adults with Type 1 diabetes who may benefit from statin therapy are not receiving such therapy. Knowledge and attitudes of both the treating clinicians and the people with Type 1 diabetes may be contributory. A network of diabetes specialists (endocrinologists) are conducting an online survey of knowledge, attitudes and experiences of both adults with Type 1 diabetes and their treating clinicians to understand contributors to undertreatment of lipid levels and their potential solutions. A pilot study is underway at 3 sites, and we are seeking funding to involve more interested sites.
Top